The investigation and management of follicular lymphoma
- PMID: 32579717
- DOI: 10.1111/bjh.16872
The investigation and management of follicular lymphoma
Comment in
-
The road to a cure: are some patients there yet? Commentary on the 2020 UK guidelines for follicular lymphoma.Br J Haematol. 2020 Nov;191(3):319-322. doi: 10.1111/bjh.16973. Epub 2020 Jul 20. Br J Haematol. 2020. PMID: 33460032 No abstract available.
References
-
- Montoto S, Davies AJ, Matthews J, Calaminici M, Norton AJ, Amess J, et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol. 2007;25:2426-33.
-
- Fisher RI, LeBlanc M, Press OW, Maloney DG, Unger JW, Miller TP. New treatment options have changed the survival of patients with follicular lymphoma. J Clin Oncol. 2005;23:8447-52.
-
- Liu Q, Fayad L, Cabanillas F, Hagemeister FB, Ayers GD, Hess M, et al. Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at the University of Texas M.D. Anderson cancer center. J Clin Oncol. 2006;24:1582-9.
-
- Swenson WT, Wooldridge JE, Lynch CF, Forman-Hoffman VL, Chrischilles E, Link BK. Improved survival of follicular lymphoma patients in the United States. J Clin Oncol. 2005;23:5019-26.
-
- Conlan MG, Bast M, Armitage JO, Weisenburger DD. Bone marrow involvement by non-Hodgkin’s lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group. J Clin Oncol. 1990;87:1163-72.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
